search

Active clinical trials for "Amphetamine-Related Disorders"

Results 51-56 of 56

To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1

Amphetamine-Related Disorders

To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.

Unknown status6 enrollment criteria

The Novel Addiction Assessment Study in Synthetic Drugs Addiction

Amphetamine Addiction

The purpose of this research is to develop an objective assessment based on the virtual reality techniques which is used for evaluate addiction severity.

Completed17 enrollment criteria

Functional Brain Imaging in Recreational Users of Ecstasy

Amphetamine-Related Disorders

Recreational use of "ecstasy" (MDMA; 3,4-methylenedioxymethamphetamine) is associated with long-lasting effects on metabolism in the human brain. The investigators propose to investigate whether chronic use of "ecstasy" is associated with impairment in motor skills and function of the dopaminergic system in recreational users of "ecstasy" compared with healthy volunteers. This will be done by scanning control subjects and "ecstasy" users at baseline and after performing on a motorbike riding computer game, while imaging dopamine in vivo with I123-IBZM (a D2 receptor radiotracer), using single photon emission computed tomography (SPECT).

Completed5 enrollment criteria

Conflict Between Maternal Autonomy and Child Health in Substance-use

Substance-Related DisordersAlcohol-Related Disorders11 more

Qualitative project, comprising open-ended semi-structured interviews with healthcare workers, who provide antenatal care to substance-using women.

Completed3 enrollment criteria

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Amphetamine-Related Disorders

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Unknown status2 enrollment criteria

Cognitive Correlates of Substance Abuse, Part 2 - 16

Amphetamine-Related Disorders

Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.

Unknown status2 enrollment criteria
1...56

Need Help? Contact our team!


We'll reach out to this number within 24 hrs